blog counter

Spectranetics Corporation
Medical Devices & Tech
96 Talamine Court
Colorado Springs, CO 80907-5186 USA
phone: (719) 633-8333
fax: 1-719-633-8791
Symbol SPNC
Exchange Nasdaq
Founded 1984
Employees 142
www.spectranetics.com
Research Sector Medical Devices & Tech
Summary Description
Devices for minimally invasive cardiovascular system surgeries.
Management
John G. Schulte, President and Chief Executive Officer; Jonathan W. McGuire, Chief Operating Officer; Guy A. Childs, Vice President, Chief Financial Officer; Adrian E. Elfe, Vice President, Quality Assurance and Regulatory Affairs; Lawrence E. Martel, Jr., Vice President, Operations; Kelly W. Elliott, Vice President, Clinical Affairs and Regulatory Submissions; Stephen D. Okland, Jr., Vice President, Sales and Marketing
Ownership
Financials Mkt Cap :312


* numbers in thousands

Recent Results
Revenue for the third quarter of 2006 was a record $16.2 million, up 44% compared with revenue of $11.2 million for the third quarter of 2005.
 
Keywords
cardiovascular, occlusions, Cardiology, cardiac, heart, coronary, heart, laser, excimer laser, catheter, sheath, minimally invasive, atherectomy, clogged arteries, obstructed arteries

Comment | Printable Version | Jul. 01, 2008
If you work for Spectranetics Corporation and want to update this profile, click here

Description
Spectranetics develops, manufactures and markets single-use medical devices used in minimally invasive surgical procedures within the cardiovascular system, in conjunction with its proprietary excimer laser system.
Products / Services
Spectranetics' excimer laser system includes the CVX-300 laser unit and various fiber-optic delivery devices, including disposable catheters and sheaths. The excimer laser system is used in complex atherectomy procedures to open clogged or obstructed arteries in the coronary vascular system. It is also used to remove lead wires from patients with implanted pacemakers or cardioverter defibrillators, which are electronic devices that regulate the heartbeat.
Technology / Differentiation
Excimer laser technology delivers comparatively cool ultraviolet light in short, controlled energy pulses to ablate or remove blockages.
Market / Customers
Coronary Artery Disease occurs when coronary arteries become narrowed or blocked by a buildup of plaque (cholesterol or other materials). When the blockage is severe, the flow of blood and oxygen to your heart muscle is reduced.
Competitors / Substitutes / Alternatives
Boston Scientific Corp., Medtronic, Inc., Pfizer, Inc.
Status
Spectranetics' excimer laser system is approved in both the United States and Europe for use in multiple, minimally invasive cardiovascular applications. In 2004, Spectranetics received 510(k) clearance from the FDA for its CliRpath laser catheters, which are indicated for use in the endovascular treatment of peripheral artery disease where total obstructions are not crossable with a guidewire.